Testing effectiveness (Phase 2)WithdrawnNCT04046107
What this trial is testing
Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy
Who this might be right for
Hepatitis B Virus
National Institute of Allergy and Infectious Diseases (NIAID)